the aid library

LIST OPTIONS

Filter

5295

Sort by:

Direction:

Download (25)

View PDF (15)

Silica-associated lung disease: An old-world exposure in modern industries

Barnes, H.; Goh, N. S. L.; Leong, T. L.; Hoy, R. Official Journal of the Asian Pacific Society of Respirology (2019) CC2

Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... more

Download (22)

View PDF (21)

Diabetes and kidney disease

International Diabetes Federation (2023) CC2

Diabetes is one of the leading causes of chronic kidney disease (CKD). Up to 40% of people living with diabetes develop CKD, and the number of new cases of CKD in people with type 2 diabetes increased by 74% between 1990 and 2017. The prevalence of diabetes-related CKD varies widely between countrie... more

Download (29)

View PDF (20)

Living with Chronic obstructive pulmonary disease (COPD)

Asthma and Lung UK (2022) CC2

Chronic obstructive pulmonary disease (COPD) is where air cannot get out of the lungs easily (the airflow is obstructed). COPD is a common condition that mainly affects middle-aged or older adults who smoke or have smoked. Jobs where people are exposed to dust fumes and chemicals also increase the r... more

Download (17)

View PDF (27)

Global Alliance against Chronic Respiratory Diseases (GARD): generel meeting report, Seol, Repblic of Korea, 1-2 June 2007

World Health Organization WHO (2007) CC2

Everyone in the world is exposed to risk factors for chronic respiratory disease (CRD). Three billion people live in urban areas and are exposed to outdoor air pollution. Two billion people are exposed to solid fuel combustion which represents one of the major risk factors worldwide. One billion peo... more

Download (27)

View PDF (21)

Childhood respiratory disease linked to the enviroment

World Health Organization WHO (2009) CC2

Childhood Respiratory Diseases & the Environment learning objectives •To understand how the respiratory tract is affected by the environment •To describe respiratory diseases linked to the environment •To list one population-level intervention and one personal-level intervention for d... more

Download (30)

View PDF (22)

Global Initiatibe for Chronic Obstructive Lung Disease - Pocket Guide 2023

Global Initiative for Chronic Obstructive Lung Disease – GOLD (2023) CC2

Chronic Obstructive Pulmonary Disease (COPD) is now one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries (LMICs). More than 3 million people died of COPD in 2012 accounting for 6% of all deaths globally. COPD represents an important public... more

Download (22)

View PDF (15)

Global Initiative for Chronic Obstructive Lung Disease - Report 2023

Global Initiative for Chronic Obstructive Lung Disease – GOLD (2023) CC2

The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha... more

Download (17)

View PDF (16)

Secondhand Smoke infographics - Center for Disease Control and Prevention CDC

Center for Disease Control and Prevention CDC (2015) CC2

Secondhand smoke and the harmful chemicals in it are known causes of Sudden Infant Death Syndrome RESPIRATORY INFECTIONS, ear infections.and asthma attacks in infants and children. They are also known causes of HEART DISEASE,stroke, and lung cancer in adult nonsmokers.

Download (30)

View PDF (24)

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

National Institute for Health and Care Excellence - NICE (2018) CC2

This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, impr... more

Download (28)

View PDF (37)

Asthma Action Plan - U.S. Centers for disease Control an Prevention

U. S. Centers for Disease Control and Prevention (2024) CC2

Asthma Action Plan Doctor’s Name: Doctor’s Phone Number: Main Emergency Contact: Backup Emergency Contact: Green Zone: No coughing, wheezing, chest tightness, or shortness of breath. Can do usual activities: Every day: Take these medicines, even if you’re not having any symptoms. Av... more

Download (49)

View PDF (36)

Global Initiative for Chronic Obstructive Lungs Disease - Podcast

Global Initiative for Chronic Obstructive Lung Disease – GOLD (2024) CC2

These podcasts are produced for educational discussions only. Reference to any specific product, treatment, or entity does not constitute an endorsement. The views expressed by speakers are their own and do not necessarily reflect the view of GOLD in entirety.

Download (16)

View PDF (12)

Cancer: Disease Control Priorities, Third Edition (Volume 3)

Gelband H., Jha P., Sankaranarayanan R. et al. International Bank for Reconstruction and Development The World Bank (2015) C2

Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packa... more

Download (8)

View PDF (9)

Cardiovascular Diseases

World Health Organization WHO (2023) C_WHO

The website provides information on cardiovascular diseases (key facts, definitions, risk factors etc.).

Download (183)

View PDF (279)

HEARTS. Technical package for cardiovascular disease management in primary health care. Evidence-based treatment protocols

World Health Organization WHO, et al. (2018) C_WHO

In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles... more

Download (166)

View PDF (255)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (14)

View PDF (12)

Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data

Marcus, M.E.; Manne-Goehler, J.; Theilmann, M. (2022) CC

Background In the prevention of cardiovascular disease, a WHO target is that at least 50% of eligible people use statins. Robust evidence is needed to monitor progress towards this target in low-income and middle-income countries (LMICs), where most cardiovascular disease deaths occur. The objectiv... more

Download (89)

View PDF (67)

Noncommunicable diseases and climate change

World Health Organisation (WHO) (2022) C_WHO

WHO has identified climate change as one of the greatest health threats of the 21st century and air pollution as the single largest environmental health risk. Noncommunicable diseases (NCDs), including cardiovascular diseases, diabetes, chronic respiratory disease and cancer, are the leading causes ... more

Download (14)

View PDF (9)

Noncommunicable Diseases Fact Sheet

Pan American Health Organization PAHO (2024) C_WHO

Chronic noncommunicable diseases (NCDs) are the number one cause of death and disability in the world. The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care. The... more

Download (12)

View PDF (12)

Noncommunicable diseases and air pollution

World Health Organization WHO (2019) C_WHO

Air pollution is the second leading cause of deaths from noncommunicable diseases (NCDs) after tobacco smoking, according to WHO.

Download (13)

View PDF (7)

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

The WHO CVD Risk Chart Working Group The Lancet Global Health (2019) CC

To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, validation, and illustration of the revised WHO cardiovascular disease risk ... more